Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FY.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FY.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.497NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.497NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.497NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EN.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EN.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EN.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.30 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.30 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.30 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.85 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.85 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.85 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.6.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.6.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.6.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.21NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.21NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FK.1.3.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FK.1.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FK.1.3.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBFNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBFNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBFNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.11.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.11.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.11.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBF.7.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBF.7.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBF.7.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.5.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FY.5.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.5.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FP.2.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FP.2.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FP.2.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.9NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.2.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.2.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JW.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used